COSMOS Pharmaceutical Corporation

CSMYF · OTC
Analyze with AI
8/31/2025
5/31/2025
2/28/2025
11/30/2024
Assets
Cash & Equivalents$337$57,038$22,765$39,129
Short-Term Investments$0$0$0$0
Receivables$5$12,240$672$683
Inventory$606$92,323$88,059$93,850
Other Curr. Assets$134$4,021$15,367$16,358
Total Curr. Assets$1,083$165,622$126,863$150,020
Property Plant & Equip (Net)$2,290$348,162$320,043$326,259
Goodwill$0$0$0$0
Intangibles$5$446$431$453
Long-Term Investments$30$0$0$26,391
Tax Assets$0$2,913$0$0
Other NC Assets$158$7,608$26,764-$16,555
Total NC Assets$2,482$359,129$347,238$336,548
Other Assets$0$4$0$3
Total Assets$3,565$524,755$474,101$486,571
Liabilities
Payables$1,217$177,125$156,818$173,939
Short-Term Debt$37$7,938$8,006$4,331
Tax Payable$0$11,651$0$7,874
Deferred Revenue$0$0$0$0
Other Curr. Liab.$215$23,966$30,840$26,689
Total Curr. Liab.$1,469$220,680$195,664$212,833
LT Debt$245$42,019$20,523$21,344
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$65$4,593$9,092$8,908
Total NC Liab.$310$46,612$29,615$30,252
Other Liabilities$0$0$0$0
Cap. Leases$0$7,073$0$0
Total Liabilities$1,779$267,292$225,279$243,085
Equity
Pref Stock$0$0$0$0
Common Stock$28$4,178$4,178$4,178
Retained Earnings$1,724$248,309$239,674$234,335
AOCI$1$0$96$98
Other Equity$33$4,975$4,874$4,874
Total Equity$1,786$257,462$248,822$243,484
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$3,565$524,754$474,101$486,569
Net Debt-$54-$7,081$5,764-$13,454